Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
'Switch-to' or 'add-on' PegIFN alfa in NA-treated chronic hepatitis B with low HBsAg
ChiCTR-OPC-16008586Phase 4Not yet recruiting
- Sponsor
- Center of Infectious Diseases, West China Hospital, Sichuan University
- Start
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of pegylated interferon alpha in Chronic Hepatitis B (CHB) (2 arms), sponsored by Center of Infectious Diseases, West China Hospital, Sichuan University. Primary endpoint: HBsAg clearance. Planned start Jul 2016; status: not yet recruiting.
02
Drugs
pegylated interferon alpha
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-OPC-16008586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008586.